195 related articles for article (PubMed ID: 15757889)
1. c-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells.
Mukherjee S; Conrad SE
J Biol Chem; 2005 May; 280(18):17617-25. PubMed ID: 15757889
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.
Doisneau-Sixou SF; Sergio CM; Carroll JS; Hui R; Musgrove EA; Sutherland RL
Endocr Relat Cancer; 2003 Jun; 10(2):179-86. PubMed ID: 12790780
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
Cariou S; Donovan JC; Flanagan WM; Milic A; Bhattacharya N; Slingerland JM
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9042-6. PubMed ID: 10908655
[TBL] [Abstract][Full Text] [Related]
5. The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells.
Skildum AJ; Mukherjee S; Conrad SE
J Biol Chem; 2002 Feb; 277(7):5145-52. PubMed ID: 11741909
[TBL] [Abstract][Full Text] [Related]
6. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
Liu J; Li J; Sidell N
Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884
[TBL] [Abstract][Full Text] [Related]
7. Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells.
Chen X; Danes C; Lowe M; Herliczek TW; Keyomarsi K
J Natl Cancer Inst; 2000 Sep; 92(17):1403-13. PubMed ID: 10974076
[TBL] [Abstract][Full Text] [Related]
8. Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells.
Mandal S; Davie JR
J Cell Physiol; 2010 Jul; 224(1):28-32. PubMed ID: 20301197
[TBL] [Abstract][Full Text] [Related]
9. Functional ablation of pRb activates Cdk2 and causes antiestrogen resistance in human breast cancer cells.
Varma H; Skildum AJ; Conrad SE
PLoS One; 2007 Dec; 2(12):e1256. PubMed ID: 18060053
[TBL] [Abstract][Full Text] [Related]
10. p53-independent induction of G1 arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-Myc.
Jeong JH; Kang SS; Park KK; Chang HW; Magae J; Chang YC
Mol Cancer Ther; 2010 Jul; 9(7):2102-13. PubMed ID: 20587660
[TBL] [Abstract][Full Text] [Related]
11. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
[TBL] [Abstract][Full Text] [Related]
12. Suppression of c-Myc enhances p21
Jeong YJ; Hoe HS; Cho HJ; Park KK; Kim DD; Kim CH; Magae J; Kang DW; Lee SR; Chang YC
J Cell Biochem; 2018 Feb; 119(2):2036-2047. PubMed ID: 28833404
[TBL] [Abstract][Full Text] [Related]
13. Identification of functional networks of estrogen- and c-Myc-responsive genes and their relationship to response to tamoxifen therapy in breast cancer.
Musgrove EA; Sergio CM; Loi S; Inman CK; Anderson LR; Alles MC; Pinese M; Caldon CE; Schütte J; Gardiner-Garden M; Ormandy CJ; McArthur G; Butt AJ; Sutherland RL
PLoS One; 2008 Aug; 3(8):e2987. PubMed ID: 18714337
[TBL] [Abstract][Full Text] [Related]
14. Endothelial p21(WAF1/CiP1) cell cycle inhibitor is down-regulated in breast cancer.
Vrekoussis T; Stathopoulos EN; Kafousi M; Saridaki Z; Sanidas E; Zoras O
Anticancer Res; 2005; 25(4):2743-8. PubMed ID: 16080520
[TBL] [Abstract][Full Text] [Related]
15. The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome.
Butt AJ; Sergio CM; Inman CK; Anderson LR; McNeil CM; Russell AJ; Nousch M; Preiss T; Biankin AV; Sutherland RL; Musgrove EA
Breast Cancer Res; 2008; 10(2):R28. PubMed ID: 18373870
[TBL] [Abstract][Full Text] [Related]
16. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH
J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357
[TBL] [Abstract][Full Text] [Related]
17. 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression.
Hong C; Kim HA; Firestone GL; Bjeldanes LF
Carcinogenesis; 2002 Aug; 23(8):1297-305. PubMed ID: 12151347
[TBL] [Abstract][Full Text] [Related]
18. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
[TBL] [Abstract][Full Text] [Related]
19. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells.
Blagosklonny MV; Prabhu NS; El-Deiry WS
Cancer Res; 1997 Jan; 57(2):320-5. PubMed ID: 9000576
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E2 modulates cell cycle function to promote proliferation in pancreatic cancer cells via regulation of the c-Myc-p21
Du S; Wang H; Cai J; Ren R; Zhang W; Wei W; Shen X
Biochem Cell Biol; 2020 Apr; 98(2):191-202. PubMed ID: 32167787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]